Zealand’s AI-driven obesity drug collaboration could redefine treatment strategies, emphasizing multispecific proteins for complex conditions.
The post Zealand Pharma taps Generate’s AI in obesity deal worth up to $1.2 billion appeared first on Crypto Briefing.